[
  {
    "ts": null,
    "headline": "Molina Healthcare’s Q4 Earnings Call: Our Top 5 Analyst Questions",
    "summary": "Molina Healthcare’s fourth quarter results were marked by pronounced margin pressures, leading to a significant negative market reaction. Management attributed the underperformance to continued high medical cost trends in both Medicare and Marketplace, and unexpected retroactive adjustments in Medicaid, particularly in California. CEO Joseph Zubretsky described the quarter as disappointing, noting that “retroactive items in Medicaid totaled $2 per share,” and emphasized that elevated utilization",
    "url": "https://finnhub.io/api/news?id=72c751eeb9fad92e18c9cac2c44382fb54495e6d3de5d6efe5011003e4a211e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770874511,
      "headline": "Molina Healthcare’s Q4 Earnings Call: Our Top 5 Analyst Questions",
      "id": 139054024,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MOH",
      "source": "Yahoo",
      "summary": "Molina Healthcare’s fourth quarter results were marked by pronounced margin pressures, leading to a significant negative market reaction. Management attributed the underperformance to continued high medical cost trends in both Medicare and Marketplace, and unexpected retroactive adjustments in Medicaid, particularly in California. CEO Joseph Zubretsky described the quarter as disappointing, noting that “retroactive items in Medicaid totaled $2 per share,” and emphasized that elevated utilization",
      "url": "https://finnhub.io/api/news?id=72c751eeb9fad92e18c9cac2c44382fb54495e6d3de5d6efe5011003e4a211e3"
    }
  }
]